Abstract
A series of small molecules bearing an α-ketoamide warhead were synthesized and evaluated for their ability to inhibit cathepsin S, a key proteolytic enzyme upregulated in many cancers during tumor progression and metastasis. Most of the synthetic compounds were noncytotoxic, but several robustly inhibited cathepsin S (IC50 < 10 nM) and potently suppressed cell migration, invasion, and capillary tube formation. These results highlight the potential of α-ketoamide therapy for preventing or delaying cancer spread.
Original language | English |
---|---|
Pages (from-to) | 4545-4549 |
Number of pages | 5 |
Journal | Journal of Medicinal Chemistry |
Volume | 53 |
Issue number | 11 |
DOIs | |
Publication status | Published - Jun 2010 |
Externally published | Yes |
ASJC Scopus subject areas
- Molecular Medicine
- Drug Discovery